A detailed history of Arcadia Investment Management Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Arcadia Investment Management Corp holds 222 shares of AZN stock, worth $17,198. This represents 0.0% of its overall portfolio holdings.

Number of Shares
222
Previous 222 -0.0%
Holding current value
$17,198
Previous $15,000 13.33%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

BUY
$54.21 - $70.44 $12,034 - $15,637
222 New
222 $15,000
Q1 2021

Apr 30, 2021

SELL
$47.16 - $54.44 $75,456 - $87,104
-1,600 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$53.07 - $61.1 $84,912 - $97,760
1,600 New
1,600 $88,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Arcadia Investment Management Corp Portfolio

Follow Arcadia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.